Stand out for this role — generate a tailored resume and cover letter in about a minute.
Aphios Corporation is seeking a Part-Time Accountant to support day-to-day accounting and financial operations at our North Reading, MA facility. This hands-on role suits an accounting professional who thrives in a small, entrepreneurial biotechnology company and values accurate, well-documented records.
You will work with Aphios’ leadership and our Fractional Controller to maintain books, process payroll, and ensure compliance with U.S. GAAP and audit-ready practices.
Aphios Corporation, a clinical-stage biotechnology company developing therapeutic products and proprietary pharmaceutical and nanotechnology platforms, is seeking an experienced Part-Time Accountant to support the Company’s day-to-day accounting and financial operations.
This is a hands-on position for an accounting professional who is comfortable working in a small, entrepreneurial biotechnology company and maintaining accurate, timely and well-documented financial records.
The successful candidate will work with Aphios’ executive and financial leadership, including the Company’s Fractional Controller, and will help maintain accounting records and supporting documentation consistent with U.S. GAAP and audit-ready financial practices.
Experience with Sage accounting software is strongly preferred. Experience with NIH, SBIR/STTR or other federal grant accounting and biotechnology or R&D organizations would be particularly valuable.
Aphios has a significant history of federally funded research and development. Experience with NIH, SBIR/STTR or other federal grants is highly desirable.
Relevant experience may include:
This is a part-time position with scheduling flexibility based on the candidate’s experience and Aphios’ requirements. On-site participation at Aphios’ North Reading facility will be required.
This position may be particularly attractive to an experienced accounting professional seeking a flexible schedule while remaining actively involved in the financial operations of a growing biotechnology company.
Aphios Corporation is a clinical-stage biotechnology company advancing therapeutic products together with proprietary pharmaceutical and nanotechnology platforms.
Our portfolio includes a planned Phase 3 clinical program for Zindol®, planned Phase 2b programs in opioid addiction and chronic epilepsy, and additional therapeutic programs progressing through IND-enabling development.
87 Main Street, North Reading, MA 01864
No phone calls, please.
Aphios Corporation is an equal opportunity employer.